The portal hypertension that develops in rodents exposed to CCL4 is the results of extracellular matrix deposition and endothelial dysfunction due to two major mechanisms, i.e. insufficient NO production and enhanced ET-1 generation [4,6–9,15–18,30–33]. Here, CCL4 is linked to liver disorder.